Home/Filings/4/0000905718-20-000012
4//SEC Filing

Bell John K 4

Accession 0000905718-20-000012

CIK 0001498382other

Filed

Jan 1, 7:00 PM ET

Accepted

Jan 2, 4:10 PM ET

Size

5.5 KB

Accession

0000905718-20-000012

Insider Transaction Report

Form 4
Period: 2019-12-31
Bell John K
Director
Transactions
  • Other

    Common Stock

    2019-12-31+299,759 total(indirect: Held by Onbelay Capital Inc.)
Holdings
  • Common Stock

    (indirect: Held by Registered Retirement Income Fund)
    35,000
Footnotes (1)
  • [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001569585

Filing Metadata

Form type
4
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:10 PM ET
Size
5.5 KB